ArticleJournal of Cancer2024

CD52 knockdown inhibits aerobic glycolysis and malignant behavior of NSCLC cells through AKT signaling pathway.

Yini Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.